Radiotherapy for prostate cancer: Influence of fiducial marker on diffusion weighted MR image

Radiotherapy for prostate cancer: Influence of fiducial marker on diffusion weighted MR image - Influence of Gold marker to MRI

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000036326

Enrollment

Registered

2019-03-28

Start date

2017-01-05

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate cancer

Interventions

MR image

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: Patients who can place gold markers in the prostate Patients for whom informed consent was obtained

Exclusion criteria

Exclusion criteria: Patients taking anticoagulant medication

Design outcomes

Primary

Measure	Time frame
The MR images taken before and after placement of the gold marker are compared and scored in five steps up to 1-5. If the point difference is large, it is determined that the gold marker affected the MR image. If there is no significant point difference, it is judged that there was no effect.	—

Countries

Japan

Contacts

Public ContactOsamu Tanaka

Asahi University Hospital Radiation Oncology

c.bluered@gmail.com0582538001

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026